Moderna’s mRNA Flu Vaccine Back Under FDA Review

Follow Drugslib on

By Deanna Neff HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 19, 2026.

via HealthDay

THURSDAY, Feb. 19, 2026 — In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

The move comes just one week after the agency refused to evaluate the company’s application, a decision that sent shockwaves through the biotech industry.

The initial rejection centered on the design of Moderna’s clinical trials.

Regulators had previously argued that the company should have tested its shot against a higher-strength flu vaccine for the older adults in the trial’s control group.

Following the rejection, Moderna modified its approach to satisfy the government’s concerns.

mRNA technology is a relatively new approach to vaccination. It gained widespread attention during the COVID-19 pandemic, when it was used to speed vaccine development.

While traditional flu vaccines inject a virus protein into the body to stimulate the immune system, mRNA vaccines supply cells with the code to make the virus protein that then stimulates the immune system.

Under the newly accepted application, Moderna is seeking two types of approval based on age.

The company is asking for full approval for adults aged 50 to 64. For those aged 65 and older, it is seeking "accelerated approval," which allows a product to reach the market faster based on early data while more research continues.

To address the FDA's previous concerns about older people, Moderna has committed to performing a post-marketing study. This means they will continue to collect data on how well the vaccine protects seniors after it is already being used by the public.

If approved, this would be the first flu vaccine to use the same messenger RNA technology that powered Moderna’s COVID-19 shots.

Moderna CEO Stéphane Bancel expressed optimism about the upcoming flu season.

“Pending FDA approval, we look forward to making our flu vaccine available later this year so that America’s seniors have access to a new option to protect themselves against flu,” Bancel said in a statement.

The FDA is expected to make its final decision on the vaccine by Aug. 5. This timeline would allow the company to distribute the shots in time for the fall respiratory virus season.

Sources

  • NBC News/Reuters, Feb. 18, 2026

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2026-02-20 09:26

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords